Rockwell Medical
RMTI
58 hedge funds and large institutions have $9.13M invested in Rockwell Medical in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 10 closing their positions.
5,100% more call options, than puts
Call options by funds: $52K | Put options by funds: $1K
19% more capital invested
Capital invested by funds: $7.65M → $9.13M (+$1.48M)
8% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 13
0.01% more ownership
Funds ownership: 0.18% → 0.19% (+0.01%)
6% less funds holding
Funds holding: 62 → 58 (-4)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$452K |
| 2 |
Millennium Management
New York
|
+$66K |
| 3 |
VCA
Verdence Capital Advisors
Hunt Valley,
Maryland
|
+$35.5K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$35.2K |
| 5 |
Renaissance Technologies
New York
|
+$21.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$207K |
| 2 |
VF
Virtu Financial
New York
|
-$73K |
| 3 |
RB
Richmond Brothers
Jackson,
Michigan
|
-$48.6K |
| 4 |
Jane Street
New York
|
-$33K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$28.4K |
RMTI Hedge Fund Activity: Q1 2022 in Review
58 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Rockwell Medical (RMTI) for Q1 2022, worth a combined $9.13M — up 19% from $7.65M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of RMTI and 6 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 14 added.
The largest buyer was Perkins Capital Management, adding an estimated $452K. The largest seller was Vanguard Group, cutting an estimated $207K.
- 58 institutional investors held Rockwell Medical (RMTI) as of Q1 2022, down from 62 in Q4 2021.
- Funds reported $9.13M of Rockwell Medical stock for Q1 2022, up 19% quarter-over-quarter.
- 6 funds opened new Rockwell Medical positions in Q1 2022 and 10 closed out, a net change of -4 holders.
- The largest Rockwell Medical buyer in Q1 2022 was Perkins Capital Management, an estimated $452K added.
- The largest Rockwell Medical seller in Q1 2022 was Vanguard Group, an estimated $207K sold.
Based on aggregated 13F filings for Q1 2022.